For some of the newer generation, all they know about Nicolas Cage is he's a walking meme generator online. But those born in the 90s and earlier look at him much differently. He was a dramatic actor, a comedian, an action star, you name it, Cage could pull it off. And yes, he had his fair share of schlock as well. So what can be done with a man in his 50s who's already done it all? Well, you make a film about him. And that film is the unbearable weight of massive talent. Before I really dive in, I just wanna point out this is my first video in the new home studio. It sounds echoey as all hell. I have strategically placed sound barriers. I have a mic that's very close to me. So hopefully what I'm hearing isn't the final product. And if it is, well, there's gonna be some growing pains in the studio. Well, we'll tweak. We'll tinker. Think about subscribing. I post tons of movie content. We're back, baby. We're doing it. And so is Nicolas Cage, although he never left. And he will promptly tell you that along with his agent throughout the film. This is an interesting film because it's one that's definitely catered to a specific audience. Those that grew up with Nicolas Cage in his prime. I just don't see going into this blind, not really knowing any of Nicolas Cage's works and thinking this was great or even good. You'd be lost through a lot of the references. And believe me, there's a good amount. Unfortunately, the references amount to nothing more than, hey, remember this film or look, there's a giant statue of Nicolas Cage and the double guns. There isn't a lot of creativity going on. We don't see him run in slow motion with white doves flying behind him. None of the naked guns satirical stuff I was kind of hoping for where they would not only reference the movies but also kind of parody them. The plot works to an extent. I think it takes itself far too serious. When the movie has a little bit more fun is when I'm really engaged. But I'll get to that in a second. Basically, it boils down to Nicolas Cage plays himself. He's in his fifties. He's struggling to find a new meaty project to attach himself to. Something that really wow's people and showcases that he is an incredibly talented actor. There's entire sites, theories, an episode of community dedicated to the fact that no one's really sure if Nicolas Cage can act or not because he'll put in one great performance over here but in the next turnaround and shit out like six really mediocre ones just straight to DVD stuff. The guy doesn't turn down a movie role. Anyway, the guy's at his lowest, can't get a job, quits acting all together and it's at that point when he gets an opportunity that he just can't pass up anymore due to debts that he owes and a daughter that's incredibly disappointed with him. Javi, a multi-millionaire, possibly billionaire, I'm not really sure, invites the guy over for a million dollars to just hang out at a birthday party. What could possibly go wrong? Everything! It turns out Harvey's in with the cartel and if Ozark showed me anything, they are not to be trifled with. Also, I just finished that season up. I'm very disappointed but maybe we'll talk about that at another time. The majority of this movie's Nicolas Cage and Pedro Pascal bouncing lines, bouncing comedy off each other. Very good chemistry, loved these two together. Pedro, man, he's such a great actor. I love everything he's been doing.  I think that would have been the tighter movie all together. It's not bad by any means. I was enjoying myself but again, I grew up with Nicolas Cage movies. I'm definitely the demographic for this. I still think they could have pushed a little bit in one direction or another, gone all in with the over the top action comedy or maybe just scaled back on some of the dramatic moments that were unnecessary. My favorite part by far is when the two guys are tripping balls and they're seeing stuff, they're running away from fictitious enemies, climbing over walls, they don't need to climb. It's a hilarious moment and definitely something I wanted more of.   Production wise, I had no problem with it. It looks pretty. It's a nice location off in an island. Music was serviceable. Nothing really stood out. Although there was some really, really obnoxious product placement. And I don't know if this was a tip of a hat to an older Nicholas Cage film that I don't remember, but the brother is eating, and this isn't even good product placement because I already forgot what it is. Tricks, I think, or Wheaties. I'm not even sure, but they do like this full dedicated moment where he pours the cereal, he's eating it, he's talking about how much he loves the product, and they even have this like perfectly framed shot of the box of cereal as the camera slowly zooms out. If it was an intentional Wayne's World type situation where they're like calling out how pathetic this product placement was, it fell flat for me. It didn't land. They didn't go in far enough, which, again, is this whole movie in general. The last thing I'll point out is we have some Cage on Cage action. Good old fashioned Cage fight in the mind. He sees a younger version of himself in his prime. It only happens a couple of times, and honestly, I found it pretty pointless. I think I said more than enough. Well, there you have it, the unbearable weight of massive talent, not bad, not great, just fine. It got the job done. I was entertained, it's under two hours. If you're looking for something to just kind of get you by for an afternoon, this will do the trick. But I wouldn't rush out by any means, especially when Doctor Strange is right around the corner. I'm excited, that looks fun. If you saw this movie, I'm genuinely curious what you thought. Leave a comment below. Like the video if you had a good time. Please think about subscribing if you haven't. Like I said, we're back. We're gonna be posting videos constantly again. And hopefully, I'll see you around. Maybe think about joining me on Patreon at Patreon.com slash Adam Does Movies. You can become a member for only a dollar a month, show some support, or become one right here on YouTube via that join button. You can also find me at Twitch at twitch.tv slash Adam Olinger where I play a myriad of games, pretty mediocrely. I'm currently into Fortnite because I'm basic. Last but not least, there's a plethora of other videos on this channel. I encourage you to check out. There's one right there next to me along with that subscribe icon thing. So there's options, there's opportunities for you.


All right. Good morning. Good morning. Thank you for joining us. I want to introduce myself briefly, and then we have a terrific panel to talk about the 100 Days Mission and delivering countermeasures more rapidly. I think everyone obviously knows that the pandemic was a catastrophe. We all also know what a destabilizing event it was. The geopolitical effects of the pandemic continue to reverberate. Most of the issues confronting political leaders today, the so-called polycrisis, have roots in the destabilization that the pandemic caused. I think it's important to remember that this was the second pandemic of the 21st century. I worked in the White House during the first one, and after the first pandemic, I had the opportunity to debrief with President Obama, and I told him that in our response in 2009 we didn't dodge a bullet. Nature had shot us with a BB gun, and the response was not validated by virtue of the outcomes. The outcome was determined by nature. Imagine if we had had two COVID scale events within a decade. That is certainly within the realm of possibility. All of the trends that are driving the emergence of infectious disease are going in the wrong direction, and we are in a state of heightened risk. I think infectious diseases and pandemics are truly a 21st century threat and one that we need to address systemically. Six years ago, yesterday, a number of world leaders, industry leaders, stood on the main stage here in Davos at the World Economic Forum, and established my organization, the Coalition for Epidemic Preparedness Innovations, to focus on developing vaccines against emerging infectious diseases. Three years ago at the World Economic Forum in 2020, we were watching COVID explode in China. In fact, on the Thursday of the 2020 World Economic Forum, CEPI announced its first vaccine development partnerships. There were still fewer than 1,000 cases of COVID that had been counted worldwide. We announced partnerships with Inovio, with the University of Queensland, and importantly with Moderna to produce clinical trial material and speed their vaccine into clinical trials. The medical and scientific response to the pandemic was nothing short of heroic. The political response, perhaps predictably, a little less so, I think. I think we can all acknowledge that. The response to the pandemic has been marked by considerable inequity of access to medical countermeasures, and particularly to vaccine. There are many root causes of the inequity that we experienced during the pandemic. I think two are really important to call out. One is structural. It's how vaccine manufacturing is currently distributed. Political leaders in countries with vaccine manufacturing capacity have to address the needs of their own populations first, particularly in times of scarcity. I think the World Economic Forum, again, is showing prescience and leadership. They have, with the U.S. National Academy of Medicine, Victor Zell and Cepi, set up a regional vaccine manufacturing collaborative to develop a framework for regions that want to expand their vaccine manufacturing capacity. And we'll have a closed-door meeting later today to talk about how that framework can be improved and then shared with regions that are interested in increasing their manufacturing capacity. And Minister Moreno, I think, might want to talk about that a little bit later. But the other root cause of the inequity was scarcity. Where there is scarcity, there will be inequity. And that's the driver of the 100-day's mission. This is Cepi's goal that we've articulated, which has now been embraced by the G7 and G20, to accelerate vaccine development even over and above what was achieved in 2020, to be able to deliver vaccines to new threats within 100 days. That would give us a fighting shot of preventing pandemics altogether and certainly of reducing their impact. Cepi is also working on the manufacturing issue. And today, actually, we have announced a new partnership with Institute Pestor Dakar, who is building a modern, modular, flexible manufacturing facility in Dakar on the African continent that will be able to deliver vaccines for Africa's use and to be able to respond to future pandemics. It's the first of a manufacturing network of developing country manufacturers that Cepi has announced. We're delighted about that. But today's topic is speed. How can we deliver medical countermeasures more quickly? What will it take politically? What will it take scientifically? What will it take in terms of regional planning? So I am really delighted to introduce the panel today. We have a terrific panel of very experienced leaders with different perspectives. Immediately to my left, of course, I think all of you know the right honorable Helen Clark, the former prime minister of New Zealand, and importantly, the co-chair of the independent panel for pandemic preparedness and response. To her left, the right honorable Tony Blair, former prime minister of the UK, founder of the Tony Blair Institute for Global Change. We're delighted to have honorable minister, Savino Augusto Jose Marino, the minister of industry and trade from Mozambique, and Dr. Albert Borla, a trained veterinarian, but of course the CEO of Pfizer, which delivered more vaccine more rapidly than any other company during the response to COVID. Helen, let me turn to you and ask you a really important question on the political side. In the midst of the polycrisis, in the midst of political turnover, how do we maintain political attention to pandemic preparedness and response? How do we maintain the thread, keep the focus? In a way, we're back to the future at where, aren't we? Three years ago, COVID was exploding in China. Here we are again, and tragically, it's exploding in China. And that, in the sense that it's an ill wind that blows no good, we'll keep COVID in the headlines and at the forefront of leaders' attention in a way that it might not have three years into a pandemic. When we wrote the independent panel for preparedness and response report, we were very conscious that there had been 16 previous such reports and commissions who wrote with recommendations, most of which sat on a shelf, and that it was very easy to enter a cycle of panic and neglect as the immediate heat of the storm passed. I think around the world, populations are over COVID, but as we know, COVID ain't over us and requires a continuing level of focus. And also, of course, it remains the moment to seize, to make lasting change so that the world can cope with a future outbreak with pandemic potential far better than we were able to do on the run this time. Can I say, I'm actually quite encouraged at the number of trains that are moving in response to not only the independent panel report, but a range of other reports and recommendations too. You do have negotiating processes in Geneva for a new pandemic legal instrument of some kind. You have the international health regulation review process underway. You have the pandemic fund at the World Bank. Not a lot of money in it yet, but it's work in progress. WTO made a little progress, but I'd like to see more, but it's focused on the task. Countermeasures, there's a lot of discussion and debate going on and undoubtedly we'll hear more about that today and very interested in what CEPI is announcing with Institute Pasteur. I think there's still a bit of a gap about what leadership and oversight is needed going forward and our panel was clear that really keeping the focus of world leaders on these issues through a kind of global health threats council is very, very important. And we'd like to see the high level meeting in New York in September focus on that. But suffice to say, we could have been well into the neglect phase because of the ongoing momentum of COVID, not least in China now. I think there's a chance to keep the focus on and get the lasting reforms that we need to do better next time learning from this rather sad experience of the last three years. Thank you. Tony, let me ask you, you've sat in a chair very similar to Helen. Interested in your perspectives on maintaining political focus as well. Yeah, well, the best way to maintain political focus because I mean, the reality is for the political debate in many, many countries now COVID is in the rear view mirror. I mean, it isn't, but believe me, most of the people sitting in Downing Street at the moment are not talking about COVID and at the G7 and the G20. I think you won't get the focus you need unless it's clear two things. One, that there is an ongoing challenge and opportunity. And I think that is not just about COVID. It's about the fact that we are going to have a whole slew of new vaccines, injectables that are going to deal with some of the worst diseases in the world that give us the opportunity to make big changes in the health of the world. And if you want the politicians to focus, they need to think, look, this is coming down the track soon. Because if you tell them about a future pandemic, they'll kind of go, yeah, maybe someone else's problem. But you tell them, actually in the next few years, you're going to have the opportunity to make a big difference to the healthcare of your population, that will focus them. But the second thing they need is to focus on the opportunities to change healthcare that have arisen as a result of our experience of COVID. Because when it's all said and done, it was still a pretty remarkable operation. By the way, Sepe did a fantastic job. You guys deserve a lot of congratulations for it. But so I think it's around things like, how do you make sure you get the right scientific cooperation and the cooperation between the regulatory authority so in the future you can clear things much faster? For example, on the continent of Africa, if we had an equivalent to the European Medicines Agency, an African Medicines Agency that allowed you to have one system, one standard, which hugely changed the way that vaccines and treatments are introduced in Africa. And I think that this issue of manufacturing, so a lot of companies learned that if they didn't have some recourse to manufacturing sovereignty, if you like, either directly or indirectly through partnerships with other countries, then they were at a disadvantage. I think there's a huge impetus now for a national digital infrastructure. Digitization in healthcare is, I think, one of the great game-changers. We should be helping countries to develop a national digital infrastructure, which they will need with these new vaccines. And then finally, it's also about showing people and showing the political leadership that you can make a positive difference to your healthcare system by adopting these measures because they've got an impact beyond any particular disease or pandemic. So I think if you want to keep the political focus, and I agree it's vital that you do, you've got to show people that this is a continuing issue. It's not a future issue. It's here and now. It's got a broad set of implications and there are a set of solutions that COVID has taught us, arising out of the challenges of COVID, to which if we apply the right political will, we can make our healthcare systems better, not just for pandemic and disease, but more generally for the health of the population. If you do that, if you do that, they'll think they'll vote in it, and if they'll vote in it, they'll focus. Thank you. Mr. Moreno, I want to pick up a couple of themes that have already been mentioned, certainly the manufacturing effort, the expansion of manufacturing, but I think Tony has pointed to some important opportunities to improve healthcare for all populations. The African Union has set a goal for Africa to develop and produce more and more of its own vaccines to achieve, I think you use the term manufacturing sovereignty and self-sufficiency. What challenges, as Minister of Industry and Trade, what challenges do you see to making that a reality? How can the world help Africa succeed in that ambition? Thank you very much. Let me start by saying thank you for inviting me for this panel. This is an opportunity to share what's happening in Africa, in a special, my country, Mozambique. I would like to start by saying that you may be aware that Africa has, as today's United States estimates, 1.4 billion people. And 1.2 of those people are in the sub-Saharan area, where the expenditure in health is not more than 2%. And this is something that has been looked very carefully. Of course, the pandemic has shown us that we need to look at infrastructures. We do like infrastructures of health. We have poor systems. We have, in Africa, lack of professionals in health. And all those things has come up with the pandemic. And what we need to do is quickly organize ourselves, put the systems working, get the partnership, the best partnership in the world. And we are lucky because, in South Africa, we have already production of vaccines. And this will help the whole continent. The challenge is, actually, as Prime Minister Blythe said, we need to get an entity, an entity who can look at all the systems. We have, in each country, complete different procedures, different systems. And when we look for the way how we need to, the way how we need to tackle the pandemic, or whatever happens in the future, it means that we need a unique system, a system that can be similar in all our countries. But, of course, we are 55 countries in Africa, and each country has its own procedures and the relation is completely different. Even if, and when it comes to the health, so you have so much different system that we need to look at that first of all. Secondly, I think there is a chance for us, as we're running for a free trade area for the whole Africa. So this is a project going on. Maybe we can check that and join the efforts and when bring the vaccine manufacturers, use it, and they quickly have the distribution system for the whole Africa. In Africa, we have all those kind of problems in health, but the challenge is putting our hands together, getting the help of the institutions, the old institutions to attract the best manufacturers of vaccines and they take advantage of the way how we think that the trade must be guided in the next step. Great, thank you. Thank you very much. Albert, first, congratulations on the recent announcement on the expansion of Pfizer's access program. That is a terrific step, but I want to come back to the theme on the 100 days mission. Pfizer broke every land speed record in delivering a new vaccine. By my count, it was 326 days from the release of the sequences to the first emergency authorization of the Pfizer vaccine. And you did that on the fly, establishing partnerships, pulling a program together, building manufacturing capacity or expanding manufacturing capacity. What opportunities do you see to further compress those timelines and what barriers need to be overcome to be able to deliver vaccines even much more rapidly than we did in 2020? Thank you. First of all, it's a great honor to be part of this panel with two ex-iconic prime ministers and acting minister of finance, you the head of SAP. It's a great honor for me. Looking back how we were able to do it, really, I don't know. It's not only the ability to execute a very technically challenged task, but it was also a series of decisions that had to be made that were 50-50. And you had to make all of them right to be able to eventually deliver in 8-8 months. And so we were blessed to be able to do it. Now, there were a lot of challenges that we faced. And there were technical challenges, including the choice of the technology, which was a technology that had not delivered any product until that time, building manufacturing capacity for a product that was never manufactured before just to give you a magnitude of the scale you're speaking now. Pfizer, before pandemic, was producing 200 million doses vaccines every year for all the vaccines that we have in the world. The first year of the pandemic, we produced 3 billion doses of a vaccine that we never had manufactured before. That's very challenging technical to do. Then logistical challenges, these vaccines had to be transferred in minus 70 degrees. We have never built in the world a logistical channel to be able to do something like that. And that can go on and on. But if you ask me what was financial challenges, as you know, Pfizer is a very big corporation, but also we never accepted money from governments. So all of that was part of the daily life that we had, all of us at Pfizer. But if you ask me what was the biggest challenge, I think was the political challenge. I think the vaccines, the COVID and the ability to deliver or not vaccines, and then after we delivered the ability to use them or not became severely politicized and became a political statement if you are wearing a mask or not, became a political statement if you believe we will have a vaccine or not. And after we had the vaccine, it became a political statement if you believe it works or not. And then we went to more extremes if you believe that COVID existed or not. All of these were constantly on our way. And you know, I'm a businessman, I'm a scientist, I'm not a politician. And the same is the same for all of my peers, right? The head of Moderna, the head of J&J, the head of AstraZeneca, that they were trying to do the same. And that we found it the most challenging of all the tasks. And that continued after the vaccine. As you know, governments, everybody was scared at that time. So what was the result? Everybody tried to protect their own nation. So the protectionist, how was manifested in our ability to deliver? Borders were closed. So you can't export vaccine. You can't send it to anybody else, other than keep it in the U.S. Keep it in India. India closed, really, their borders. Europe was the only continent that were allowing part of the production in European soil to be exported. And congratulations to doing that. But still part, right? But at least there was the first six months of the pandemic that everybody was receiving vaccine from their own soil and everybody else from Europe. So that's something that also need to give credit to them. So for me, looking ahead now, how can we make sure that we can be better prepared to do faster in an unknown pandemic that we don't know what will be the nature of it? I think we should analyze what was the success factors in this one. And I think there were so many, but one that stands out was that the world was lucky that there was a thriving life sciences sector that was at each peak of its performance that was able to strike a phenomenal collaboration during the pandemic with regulatory agencies. That's the secret. The secret that there were all these companies in the world that were ready scientifically to address the challenge and they worked hand in hand with regulators that were spending sleepless nights to be able to review the progress so that they can authorize the next step so that we can be able to move. And the second is if we're able to do it in COVID, why not we cannot repeat it in Alzheimer's, in cancer, in Parkinson's, you know, many other diseases. Those are the two characteristics. So for me, the world should start from here. How can we make sure, one, that we maintain in the world a thriving, scientifically-based life sciences sector with the partnership between private and academia and biotics? And the second is how can we take the lessons of COVID, collaboration between regulators and companies and apply them to other severe medical needs of humanity? Great. Thank you. Albert, let me stick with you, actually, and follow up on that question. I mean, Pfizer was unique among all of the companies that delivered vaccines in not taking public sector resources to support the R&D, which had to have taken incredible courage on your part on the part of your senior management to make those decisions, given the unknowns, given the untested technology. But then you described the engagement with regulators. Certainly, Pfizer engaged with governments around procurement. From your perspective, which is unique among all of the companies that responded to the pandemic, what are going to be the key factors that, in the public-private partnerships that we need to have for the future? What are the areas where we need to focus our efforts to have the right kinds of public and private sector engagement? I spoke already about the regulators. This is a highly regulated, let's say, business, highly regulated effort. Before you do anything, you need to get an approval from regulators. These steps could take five, six months. We saw the phenomenon, but Pfizer scientists will work for a week overnight. Clearly, the last night, seven o'clock in the morning, sleepless nights, press the button to send something to FDA or EMA. And then scientists in FDA or EMA will receive the dosage and will spend a week sleepless. No sleep at all so that they can turn around and send a reply in three or four days. That went magnificently well. Very well. What I felt could have been way better for all was if the restrictions in trade were not imposed. They were imposed by fear, but there was not a single country that they had full sovereign, as you said it, in the manufacturing, because although we were doing in the beginning, in Europe or in the US, the component were made all over the world and they were unique. There were pieces that we had to import from Europe to the US, from U.K. to Europe, from multiple, from China, from India, from all over the world, that if any of them was closing as a retaliation, you are not allowing me to expert vaccine, I'm not allowing you to receive nanoparticles. Then the whole world will be, so I felt that was critical. So in the next phase, I think this is something that needs to be addressed, that everybody should remain calm. We should have some rules. Nobody stops anything, because otherwise we are all going to lose, but then we have an orchestrated way to have an equitable way of distributing. Minister Moreno, let me pick up on that. Albert has talked about these trade restrictions and trade barriers. It's kind of famous in our communities that hundreds of components that went into the Pfizer vaccine, for example, sourced from dozens of countries. What opportunities do you see through current trade efforts, and you mentioned the free trade area in Africa. How can that be linked with pandemic preparedness, and particularly with the focus on enabling rapid delivery of countermeasures? Thank you very much once again. Well, the free trade area will be a very good opportunity, especially to enable the way how the distribution system can work. With the free trade area, we will, like it happens in the European Union, have no barriers for moving the goods and services from one country to another. But more than that, we will be able to use the capabilities of a country from the north of Africa to the south. I think that investing in new manufacturers in Africa can be a very good opportunity, especially because we, as I said, Africa has lack of everything in terms of medicines, in terms of drugs. We have challenges in terms of control. We have counterfeit drugs coming in from somewhere, from Asia and from America. And the challenge for us is actually making sure that all those products can be used in the country. Of course, the source of raw material, let us say, for the pharmaceutical, we have capabilities, we have potentials in Africa to produce more of them. I'm talking about the agriculture products and all those products and be used for some medicines. We have an experience now, a recent experience from Rwanda, who has started the production of medicine. It has been a success. It has put the price of medicines going down. And of course, we need to replicate that experience from Rwanda in other countries. The ones we have, the potential, the industrial potential to put new factories and new producers. As I said, well, the market is open. The market is open. The market wants good medicine. The market wants good investors. The market is looking for good products and definitely for good services. So there's an opportunity in Africa for that. Perfect. Thank you. Tony, I want to skip over you for a minute.  But, Helen, given your work on the IPPR and talking about some of the opportunities that Minister Moreno just mentioned and the financing that will be required to support that, in the context of the current fiscal constraints, the debt burden that many, many countries are facing, what kinds of financing do we need to bring to pandemic preparedness and response, and how do we take that message to stressed ministries of finance? Well, I think we saw in the current pandemic response that the model of relying on, in effect, charitable funding didn't work terrifically well. And we're now seeing with the establishment of the pandemic fund for preparedness. Conventionally agreed, I think, that you need around 10.5 to 15 billion a year being put into support for low- and middle-income country preparedness efforts. They will, of course, contribute a lot themselves, but solidarity is needed as well. And the fund is about 10% of the way to the lower end of that target. Our panel advocated what's perhaps called the jargon, a global public investment approach. And the advocates of GPI advocate that any future fund should be set up using these principles, where you set up on a sort of member-state basis on an ability to pay from each according to their means and to each according to their needs, which is how WHO or poor funding of the UN or whatever is financed. That would mean, for example, that Mozambique, as in LDC, would pay in a very, very small amount. But of course, when it came to the allocation, would be getting a significant allocation along with other LDCs. So that, I think, should be the model. If you spread, say, 10.5 billion across a cost-sharing formula like that, it actually doesn't amount to a lot for anyone, even for, say, the US, which is always by size of economy in GDP, the biggest contributor. So that would be the kind of approach that we would advocate. And I maybe hold some hope that at some point, the pandemic fund could transition to something like that. I think it's great that it's up and running, and I'm quite encouraged by the direction that I hear it's taking. But over time, if it could transition to an even more inclusive model with a more broadly-based finance, I think that would be helpful. Great. Tony, I want to switch gears slightly. We talked about the importance of linking the development of new countermeasures and capabilities to develop new countermeasures, to ability and opportunities to deliver health care in the here and now, and that that was critical to securing political buy-in. During the pandemic, we saw, as I said, there were multiple causes for the inequities of access that we saw. Even after billions of doses of vaccine had been delivered, 12 billion doses in the first year, many countries encountered difficulties in delivery. And we'd be very interested in your thoughts, maybe the work of the Institute, on how to improve access to medicine so that if we can deliver vaccines in 100 days and other countermeasures in 100 days, how do we then get them to the people that need them? Yeah, I think it's a really important question. So Albert was talking earlier about the politics of the situation. And I think there's sort of unforgivable politics and forgivable politics. The unforgivable politics is turning a public health issue into a political issue. I mean, I remember at the beginning of the onset of COVID, people saying, what do you think of the politics of COVID? How serious is this disease? And I was like, what?  I mean, it's a disease. I don't know, you're going to ask someone who knows. So what's unforgivable is turning things like whether you wear a face mask or not into a political issue.  But there's a forgivable politics, which you see also, by the way, when it comes to Russia and Ukraine and energy prices.  So the question really is, how do you create a situation in which that more forgivable political anxiety is dealt with by a plan that allows you now to work on what are the elements you're going to need in order for this to be dealt with in the future equitably and properly.  And, you know, the thing that he's saying, I think, is so important just to alight on, which is that you've got to put the different elements of the players in this that are going to be important in making sure not just that a future pandemic is well handled, but that healthcare systems are developed properly and as new treatments come online, then they're made available to more people. You've got to get the right people in a partnership together to work out how they create the mechanisms so that in the future it's better than it was in the past. And that is about getting the major pharmaceutical people, life science people, working with the regulators, with the government's understanding what it is they need to do in order to make sure that they're not left in the situation where they're scrambling for vaccine or for equipment that they're going to need, but that there's going to be sufficient provision and that there's going to be the ability to manufacture in countries in which there's not going to be the same problem. I think there's going to be a move, I think, probably to set up manufacturing hubs, but in countries maybe that are small population countries because if you're a manufacturing hub in a large population country, you're going to have to look after that population first. And I also think this issue to do with the technology and the digital infrastructure, I just want to emphasize how important I think that is because in the end you need the data, you need to know who's been vaccinated and who hasn't been. Some of the vaccines that will come on down the line will be multiple shots. So you've got to have the reasons to do with the healthcare more generally, but certainly for a pandemic or for vaccines, you've got to have a proper digital infrastructure and many countries don't have that. In fact, most countries don't have that. So again, you've got to say, okay, who are the people that can make this happen? How do you get the right partnerships in place? So my view is this is what I'm arguing with that should happen in the G20 particularly, I think which is, I mean G7 is important forum, but the G20 is the broader forum is you've got to work out what is it that you want to achieve in order to make sure that any future pandemic is properly handled and what are the partnerships that we're going to create in order to ensure that the answers you get are the right answers and then you're going to have to have the mechanisms of implementation and those mechanisms will be partly through the formal institutions that you have like the WTO, but they'll also be through organizations like yours which I think have many advantages because they don't get landed with the same bureaucracy and frankly, small P politics around them. So I think that's what we need to do, but if you want the politicians to focus on a plan, I promise you it's got to be because they think in the next few years, not in the broad future, it's going to matter to them to have that plan. Let me just make an inject a comment on my own and you raised the importance of the digital infrastructure and we saw in countries that had good digital infrastructure. Israel, for example, was with its ability to assess the efficacy and effectiveness of the Pfizer and other vaccines. The UK, where the national health system allowed very rapid evaluations of the efficacy of different kinds of approaches. They made disproportionate contributions to our understanding of COVID and to the delivery of improved clinical care when we were learning really, really rapidly. Right, one other thing, by the way, is genomic sequencing, I think. How do we establish the right network of that and how do we make sure that if you are discovering things in a country because they're doing a lot of genomic sequencing, for example, like the South African said, you don't tend to have that country feel they've got a problem because they've discovered a new variant. Well, that's exactly what we saw, of course, was that South Africa was punished for doing the right thing. And when we have to create systems and hopefully the pandemic treaty will do this, that will prevent that kind of, I think, knee-jerk backlash. It's hard to avoid. We've got maybe just a minute or two. Let me ask anyone on the panel if there were thoughts that were stimulated by the comments of your fellow panelists. If you wanted to inject any last thoughts.  The last thought, perhaps, would be to get some discussion around the various possibilities for countermeasures going forward. And I've put my name to a Lancet comment which talks about the importance, really, of building on this concept that WHO has begun with the regional mRNA hub. It could be expanded, obviously, to different locations and a wider range of technologies. But I think having a system where scientists around the world's regions, from LMICs to HICs, are able to collaborate and cooperate on designing what we need for the future is important. I think there's also governance and financing issues going forward as to how we support the development of that and then the equitable rollout. And I think the regional manufacturing is just a no-brainer. We need distributed manufacturing for all the reasons that have been raised. And you made in your opening comments, Richard, the point about both the structural issues and the scarcity. I think we've got a chance of overcoming both of those. Great. Thank you. Let me just briefly sum up, and then I'll invite Sean Bishan up to make a couple of concluding remarks. It's been a great session. We've covered a wide range of topics, from scientific discovery, from risk-taking in industry, to the need for trade agreements, to efforts to expand manufacturing, to issues of financing and delivery of healthcare and how we can link what we are trying to do to advance pandemic preparedness with the delivery of healthcare every day and to help politicians see that as an opportunity, so that this is something that they can continue to focus on. Tony, I liked your forgivable and unforgivable politics. I haven't heard that distinction before, but I think it's very apropos. With that, I want to thank all of you for coming. Let me invite Sean Bishan up. I think he wants to make a few quick remarks. Thank you, Richard. So good morning, everyone. My name is Sean Bishan, and I head up the Health and Healthcare Division here at the World Economic Forum. So first of all, from World Economic Forum, a big thank you to you, Richard, for moderating this session. And huge thank you for our speakers. Right on Rebel Prime Minister Clark, right on Rebel Prime Minister Blair, on Rebel Prime Minister Moreno, and Dr. Burla. Great comments, very useful. One thing I want to make sure that we emphasize here today is, as Richard also pointed out, this is a sixth year anniversary for CEPI. CEPI was created here in 2017 at the annual meeting right here in Davos. And what a great success it has been. It's been a fantastic success. Richard has done a great job of leading this organization. So big hand to Richard and big hand to CEPI. It's a great, we have been talking about public-private partnership. It's a great example of public-private partnership. Obviously, there is GAVI that was created here several years ago, and both GAVI and CEPI has been so instrumental during this pandemic, during COVID-19 pandemic. It's also because of Richard's leadership that 100-day mission that we talked about is now included in G7 health agenda, which is a great achievement. I think we need to get it on top of G7. And as you said, Prime Minister Blair, it should be also part of G20 agenda. Two other things I would like to point out here in my closing remarks, in terms of what we are doing from the World Economic Forum to help on the pandemic preparedness side. One is Richard you already mentioned, and so did the Prime Minister, and in terms of the regionalized vaccine manufacturing. So regional vaccine manufacturing, we launched this initiative at the World Economic Forum together with Victor Zhao, President of National Academy of Medicine and CEPI about a year ago. And it's coming up with Roadmap, which will be discussed today actually at four o'clock. I think, Laura, at three o'clock, sorry. So I invite people here, you know, whoever can join to look at what we have done and then what's the opportunity going forward. And then the second one is, again, Prime Minister Blair, you talked about the pathogen surveillance. We are working with Africa CDC. We are working with public and private partners to bring that together so that we can all access, as soon as there is a pathogen that we identify, we can have access to the data. The whole world can have access to data. We don't repeat the South Africa example. We don't penalize countries for sharing their information, for sharing the data. And we come up with medical countermeasures, whether it's vaccines, diagnostics, or treatments. So I think that's something that's very important, and we have launched that initiative. We are working on that. So that's, I think, very critical here. I don't think we are going to avoid outbreaks. Those will happen the way we live, with the growth of population, with climate change, infectious diseases will come through, there will be outbreaks. How do we stop them from blowing into pandemics? That's the question. How do we catch those early on so that we can come up with these medical countermeasures and stop those? So with that, I know we are over time. So I will stop here. Thank you again, Richard. Thank you again, speakers. And everyone for participating here. Thank you.


Karma is coming for the narcissist, the narcissist targeted you, they love bombed you, they devalued you, they lied, they future faked and then they discarded you, they used up everything that you had to offer, until there was nothing left or they got bored, or until you finally said no more, and then they left you for someone else, someone who is meant to be a bigger bed and deal, someone who has more to offer, because you were never enough for them, but when the narcissist does this, they don't suspect that karma is coming for them, they're not anticipating it, so karma often catches them off guard, so they get the full blow, they get the full effects of their karma, the narcissist thought the grass was greener on the other side, they thought that other people were in a better situation, they weren't satisfied with you, because they have these insatiable desires that can never be fulfilled, nothing is ever enough for them, so they got rid of you with the assumption that there are better things in other places, but instead they ended up with someone who is foolish and incompetent, someone who lacks good sense and judgement, someone who is unwise and someone who lacks adequate ability, but this happens a lot, narcissists always think the grass is greener on the other side, they always think that other people have it better, they take advantage of opportunities as and when they arise, regardless of planning or principle, regardless of preparation or arrangement, because they lack moral rules and beliefs that would help them to know what is right and wrong, which would have influenced their actions, which is why they will go forward with it, because they are looking to gain something materialistic, they are looking to gain money, cars and clothes, they are not looking to gain anything of a valuable substance, so they are not going to value or be committed to anything that they have with you, they will wonder off, they will lose their way, like a homeless person or a stray cat or dog, but when they do that, they run into people who know how to play the game, people who know how to create the illusion of having something better, of having something more, of being able to meet the narcissists desires and needs, nothing is perfect, nothing goes without problems or difficulties, but when problems arise, the narcissist begins to look elsewhere, they begin to look at other people's relationships, they begin to look at what other people are doing and they are accepting people as they claim to be, they accept it and believe it without thinking about it, rather than studying it more closely, so they don't realise that what we see from the outside is all a facade, it's all a deceptive outward appearance, it's a false display, it isn't real, they have the same issues that you're going through, they have the same arguments, it's not as pleasant as it looks, but the narcissist is always looking for the bigger better deal, they're always looking for their next shiny new toy, so they believe what they see and they react to it, they start to distance themselves, because now they're looking for this new situation, which in their minds is going to be a lot better than what they had with you, but there are a lot of corn artists out there, people who exaggerate and lie, people who speak nonsense, there are other narcissists, there are people who modify their game, to bait these types of people in, people who have just left a relationship, people who are deeply impressed and astonished, people who have their eyes wide open with interest curiosity and amazement, people who are looking for anything that could be better, the corn artist baits and hooks the narcissist by creating a facade, by selling a dream, and it gives the narcissist a sudden feeling of excitement and pleasure, but it's done in a skillful and dishonest way, it's a scam, but there's a reason why the narcissist gets so caught up in it, there were certain things that you wanted and desired from the narcissist, but they were very lazy, they neglected you, they made less effort than before, because you were being realistic about things in life, you were showing a sensible and practical idea of what can be achieved and expected, you were showing a practical awareness of things as they are, you weren't selling them a dream, you weren't showing them a fantasy, so you became boring to the narcissist, but this new person they're dealing with has created a character that is fun and exciting, that gives them excitement and pleasure, because they're selling a dream to the narcissist, and the narcissist falls for it, they've been completely tricked and deceived, but in their minds they think it's exactly what they needed, they think it's what they were looking for, so they might be very kind and generous to this new person, because they don't realize they're being deceived, they might start doing more, they might do the things that you wanted them to do, they might do more than what they did with you, and this new person will be kicking game, they will be very charming, because there's an exchange, they're getting something in return, this new person is creating the facade, they're creating the illusion, they're future faking, they're making all of these false promises for the future, without taking the steps to make it a reality, and the narcissist is dealing with it with a lot of effort and energy, because they think it's everything that they were looking for, they think their dreams have come true, so they're extra, they're doing the absolute most for no reason, they're showing off, they're thirsty for attention, because they want to be chosen by this new person, but this new person isn't serious about anything, they're just engaging it for recreational use, they just see it as a form of amusement and enjoyment, it's just a form of entertainment, they're enjoying the reactions from the narcissist, and how the narcissist was willing to kick you to the curb, and throw you under the bus, and portray you as less impressive and important, and talk bad about you, it gave this new person excitement and pleasure, because some people actually get excited and aroused by this type of stuff, they find it amusing, it makes them happy and satisfied, to have someone leave a person who was meant to be significant and important to them, and they were the cause of it, it's a typical thing that narcissists do, they enjoy it, it makes them feel like they're the best, because they got the narcissist to leave you, and you may be married to the narcissist, or you may have children with them, and now the narcissist is with this new person, and they do everything they can for them, but it's just something they do to feel better about themselves, it's something that seems good, but it's not real or effective, it's done to take away attention from an embarrassing and unpleasant issue, it's intended to deceive and confuse you, but the problem is that they only pretended to have it all together, when in reality that excitement and pleasure doesn't last very long, and because they didn't have to work hard for it, they spend the money very quickly, and then they're back to square one, they're broke, and they end up being in worse condition than you were, and this is where karma gets them, because now they're stuck, they said all of these things about you, they told their family and friends that they'd done with you, because there's all of these things wrong with you, but now they've discovered that the real issue is where the person they ran off to, and they may have married this new person, they may have had children with them, they may be living together, but it's all for nothing, because once the scheme and deception has been revealed, it's all over, the new person is going to drop the narcissist, because they were never invested for the long run, they weren't planning for the future, it was just fun, but the narcissist bought into the dream, they thought they could find a bigger, better deal than something that was already good, they bought into the illusion that they could get better, but that mentality ran them into something that broke them down, something that brought them right back to reality, because life doesn't work that way, but they've put themselves in such an embarrassing situation, they can't even come back to look at you, especially if you know how badly they were treated, you will probably never see them the same way again, it's done, and then they're left with nothing, because the new person didn't have anything to lose anyway, they just saw it as a game, the narcissist thought they were about to gain an advantage over you, they thought they had found something better than you, but instead they ended up being treated like a prostitute, they were waiting on the corner to be picked up and then dropped back off, and often times they were just used as someone else's punishment, maybe the new person wanted to punch their ex or someone that they were dealing with, and at the same time they were used as your punishment, you were just another person on their carousel of pain, and the new person just bought their way into the narcissist life, they treated the narcissist like a prostitute, they were just using the narcissist for a good time, and it's not a good feeling, they had a much better situation when they were with you, but they failed to notice and consider you, they took it for granted, they minimized your value, just so they could chase a dream and end up with nothing, they end up worse off than when they left you, thank you for watching, I hope this video resonated with you, please like, comment, share and subscribe, if you would like to donate, my PayPal link is in the video description, coaching inquiries, you can email me at coaching.naksa5.co.uk, thank you for watching and I'll talk to you soon.


TfNN, headline news update. Hi everyone, Basel Chapman on the 19th day of December, getting close to wrap-up time and we're looking at the Dow at an all-time high, 28,344, high today so far is 28,381 and just bumping into a little resistance here, legs see this, it should still be a leg deep and you can't get that until next week because to make a peak seeing your lower height tomorrow and that leaves a leg deep and we're always looking at least for four higher peaks and in the weekly chart still very strong in legs see S&P exactly the same thing S&P and leg C, leg D though in the weekly chart and you can't get a leg D in the week and the daily chart until early next week this will be Monday or Tuesday so we're looking at up 967 at 3200 and the high today so far is 3202.71, the QQQ, NDX100 trading vehicle only a leg B and that means that it won't make a high until next week sometime going for that leg D at 210.47 up 92 cents leg D in the weekly chart and all of the monthly charts look very good it's the 120-minute charts we'll be looking at in my show coming up the Tiger Technicians Hour and that'll be in another few minutes and I'll sign the author of the opening call to 80 Newsletter let's look at the IWM IWM had been the laggard it's now moving up a little bit up 32 cents at 165.34 and I believe I need to call this a leg C F C only a leg C in the weekly chart and now we go to gold and gold at this particular moment is up $4 at 1483 so it's been a choppy move in this rectangle formation being repelled at this 50-period the little dash gray line 50-period moving average but the MACD is good stochastic quite weak at 70% it's just stuck in a range silver's the same thing up silver is up a little but look at the dollar this is going to be very important the dollar right now is holding quite nice he's trying to test the 14-period exponential moving average it's come off the bottom of 96.72 trading in 97.40 unchanged it's a start it needs much more to go to really get back into buy mode and that needs to get to the 97.70 97.83 area so we'll see about that and crude oil it's gonna be quite interesting because crude oil is moving up yet again some 43 cents at 61.28 we'll talk about bonds and everything else when we get back for the Tiger technicians hour coming up in a few minutes hope to see you then otherwise we'll see you tomorrow have a great day


Systematic reviews and meta-analyses are important tools used to summarize research findings on the effectiveness and safety of healthcare interventions. However, the quality of reporting of such studies can be improved by following the preferred reporting items for systematic reviews and meta-analyses, Prisma, Statement. This statement provides a checklist of 27 items and a four-phase flow diagram to help authors report systematic reviews and meta-analyses clearly and transparently. This article was authored by Alessandro Liberati, Douglas G. Altman, Jennifer Tetzlaff, and others.


Hey everyone, welcome to this week's video update today is I'm actually recording this on the morning of Saturday, February 22nd Hope everybody had a great week of trading had some action Monday obviously was closed for president's day. So I had a four-day trading week But got some nice action at the end of the week. So let's go ahead and jump right in to the alert starting on Tuesday the 18th and Our first trade alert was a rolling adjusting trade in IWM So we have this long-put vertical that we're holding on for that short Delta and of course that did benefit us Thursday and Friday with the market sell-off. So we just rolled it rolled this out to April with 59 days Extended that duration to keep that short Delta in our portfolio We're at about between one and one a half to one on our short Delta versus our theta ratio And here's our IWM trade and what you'll notice is we actually when we roll this out Typically, we like to roll it so we get about a 60% probability of profit We rolled this out with less just because we wanted a little bit more short Delta get a little bit more short In our overall portfolio and so we narrowed that so it's a lower pop But gives us a more benefit to the downside if this if this thing does continue to run to the downside Next trade was a closing adjusting trade in wheat So we closed out one set of our iron condors only had three days to expiration at that point got a nice move higher nice bounce higher Wheat moved up about at the time. We took this off. It was up about two and a half percent on the day And so we were able to book a nice profit on that piece of the trade Now we're still holding another piece our other iron condor and you see prices Pretty well centered in that one. So just waiting for some more time to pass on wheat Next trade closing trade in SPX. So we had one of our iron ducks price had run higher, so we just booked that beak profit and Still had six days expiration. So there's no reason to hold it tie up that capital for another six days There's very little chance of it getting back to the Duck head now looking after the week has ended now with the two Down days, you know, it's probably got a better chance of getting down But you can't play in hindsight like that. So we took those profits and we're able to redeploy that capital I'll get to SPX on the platform here in just a second because we did add another one in But the next trade opening trade in Amazon. So we put on a duck with 10 days to expiration in Amazon so we take a look at that I can see prices come and come down after the sell-off here late in the week and we're pretty pretty centered in that duck head and So, you know, we always we always love to be able to put these iron ducks on after a down day But you also have to stay active and you never know when that's coming So we you know we put a couple of these on a couple of ducks on early in the week And then of course price dropped and so they're already right in our duck head, but that's okay I mean, that's right where we want to be as long as you know We don't get a another flush down where we're in fine shape on these iron ducks Now we also have short delta. So a down down move would help those positions So you're kind of looking at it all in a portfolio setting but managing each trade separately Next trade closing trade in Nvidia So we had a post earnings short put vertical in Nvidia booked over 50% of max profit on That trade so that was a nice one In fact, if we would have held the next day, we got even a further move higher So we got out on this day here after we we got this and booked 50% of max profit right here And then the next day just it fired up even higher Of course, it's retraced the last couple days with the rest of the market, but good trade in Nvidia Next rate closing trade in oil and CL so we closed out our short strangle in oil This thing was kind of hanging out in the lower end of the range all cycle You know with this big down move and then You know towards the end. We just got this little bounce and we're able to book 50% of max profit We did get back in with a another alert And so we are back into oil and you can see played volatility contracted a tiny bit since we put this on So we were up a little bit of money. It's playing the waiting game in oil Next trade rolling adjusting trade in XBI so price had moved up the range of our short strangle It had not as I mentioned here. We did not Breach the short call we did not breach the break even but the main but that's really just a reference point our main focus on these of when to adjust is if there's very little value left in those puts or the untested side Then there's no you know if it continues in that direction that it's not giving us really any help And so that's when we want to adjust and so that's what we did and we just rolled those puts up Stayed in the same cycle because there was 30 days to expiration still so we just kept it in March So if you take a look at XBI You can see it's come back down basically right to center now And this this kind of if you haven't if you're newer and you haven't done this before just remember You know after you adjust it's gonna look like you're you know, you're way down on the trade It shows down $336 but what this what what the platform doesn't take into account is the credit that you already booked on the Puts that you closed out. So Keep in mind when you're looking at this, it's not gonna give you a true accurate depiction of where you are P&L wise Because we've already booked that that credit on the on the put side that we closed So hopefully that makes sense. We talked about that in the short strangles course as well Next trade closing trade in Google. So we closed out an iron duck price had run higher So we booked the beak profit on that We entered a new Google trade, which I'll get here in a second Another opening trade put on another iron duck in Roku this one with 16 days to expiration So just layering on these ducks with different expiration cycles And so if you take a look at Roku kind of a similar situation situation is Amazon With this down move in the market came down into center now. I had I had somebody in the community Say something about that thinking that we were at kind of our exit point, but We have a max profit of $500 so we're not gonna get out till 500 And you know, if we were down 500, which is way down here. So And again, we're right in the middle of the duck head right where we want to be now We got there pretty quickly and swiftly. So sometimes that makes people nervous, but But that's we're in good shape in Roku at this point Next trade rolling just in trade in ES. So this is our long put vertical that we're holding for that short delta exposure So we just extend this extended this one out to 57 days to expiration Now keep in mind the markets closed. So you're not seeing the P&L line here Sometimes these things the analyze tab can act a little goofy, especially in futures when the markets close But prices right here We did move down with the market down move the last couple days and we've got a little bit of profit here since our role But it's not showing the P&L line at this point. So don't don't worry about that It'll all adjust and fix itself in the market opens Next trade with this was the opening trade in Google. We did this one with 15 days to expiration So if you take a look at that, you can see actually, this is this was the one that somebody had a question on We've got a max profit of $700. So we wouldn't exit this thing into her down at least 700 And we're only we're down for something because it came into center here But you know still a lot of time left. So nothing to do on that Closing trade and shop this one was really frustrating. I really liked this one. In fact in my other account I actually added to this one Because of the price action that we were seeing but you know anytime you get a huge flush down in the market It's gonna take everything with it. And so You know, this was the line after they announced earning This was the line of the expected move and you can see prices continue to react off that bounce off that bounce off that and You know, I was anticipating just you know that continuation to the upside However, that's not what we got. We got the downside. So we went ahead and closed that out took a loss on our shop Post-earning short put vertical. I think that's the first loss on one of those short put verticals that we've had in a couple of years And that goes for both the alerts and I can't remember one that we've lost on That I've taken in in my personal account either. So they've been really solid But of course nothing was 100% so we ended up taking a loss there now I I still wouldn't mind getting back in here next week, you know A lot of times they'll bounce off the expected move and then it'll also bounce off of the last price And so we've kind of come back down and come close to that Probably won't do I don't know we may do we may do a short put vertical depends on where our overall portfolio is with our with our with our Delta ratio, but you could do another short put vertical or the other thing We might look at is just doing an iron duck where we have that no risk to the upside But we've got a huge buffer to the downside So we'll be looking for potential trades and with implied volatility spiking I mean there's gonna be a lot of opportunity across the board and shop being one of those Next trade opening trade in SPX so we put on another iron with a big down move on Friday We put on a new iron duck with 21 days to expiration. So if we take a look at that So now we've got two different ducks Here's the one from that alert with 21 days to expiration see prices pretty close to where we put it on We just put that on after the down move on Friday And then we've got our other one which expires in I think five or six days and prices just entering the duck yet So just where we want it there So that one has Okay, that one has nine days and then that one has well now 20 at Saturday at the time it's recording so That's our SPX ducks Then we I'm already mentioned this and show this this is our new opening short strangle in CL in oil We did this with 55 days to expiration and then lastly a closing trade in Delta Airlines So this was that long put that we put on you know with the coronavirus scare and then the airlines talking about shutting Shutting flights down out of China We just wanted to get short and airline stock and that's what we did here now we We we got out of a tiny loss almost a break even I think we lost $19 overall home of trade But we put this on back here and we were hoping to get a flush down and it just bounced higher And then we did get that flushed today And we got out pretty close to the lows and it did rally back So it's a good exit but that was the last trading day for that option cycle So we had to exit so we were out of that So those are all the alerts. Let's take a look at some of the other positions gold So we've got this the one piece from our previous iron condor and so we've got a few days left until expiration You can't get assigned on gold futures And so we're just holding this up to expiration if we can get a flush lower and get back a little bit Then then that's the goal there Otherwise we're gonna close that early next week and then we've got the full iron condor We can see prices coming up and it's break breaching our break even here If we look at just the put side you can see we still got a little bit of chunk of premium left In those options so that I wasn't quick to adjust this So I was gonna give it over the weekend if we get a down movement will be back in range If price does continue higher then we will close out this The the put vertical side and then we'll potentially add to gold because we'll close out this one in the mars cycle We'll be left with just the call vertical side In the April cycle and so probably add another full iron condor in gold Natty gas along with the other energy has had a nice bounce so it's come right back up into center here So just continuing to Wait on that one. We've got plenty of time. Yeah, 33 days in Natty gas So just continuing to hold on to that one I would like to add to this if implied volatility is still high or if it you know moves to one of our Near one of our break evens on either side, but for now we're just holding ZB This was one again, don't pay attention to P&L line But this was one that was dead centered and we were close to taking off just waiting for a little bit more We were we're gonna be able to get out of this trade at an overall profit from where we started And we've been continuing to adjust and roll this trade Then obviously with the down move price in the down move in stocks Created an up move in bonds and so we're now we're up here So what I'm looking to do is I would potentially want to add to this implied volatility is nice and high So we could do another kind of a centered short strangle around that This current position has 34 days and then the May cycle at this time has 62 So early next week will be down in our wheelhouse of under 60 days So we would look to add a short strangle in the May cycle, which is what we will potentially do Of course, if we get a sharp move lower in bonds get back to center We'll probably just book profits here and then you know potentially re-enter a new position out in May But we'll we'll look at that early next week. I Mentioned wheat Apple nice move down today down over a couple percent And down on Friday, I should say so we've after our role we've we've Created a little bit of profit since that role and so we're still battling Apple I mean we've had this on for short delta and of course Apple's just continued to rally So we'll continue to keep this on if we get a little bit lower move and Apple early next week We will roll these Roll these strikes down and kind of collect that credit and continue to extend duration We've got 27 days on this so if we did that we would probably also move that out till April with 55 days Amazon I mentioned de so this was one. We were actually hoping to put on a Post-earnings short put vertical so the the expected move was about four and a half So closed at about call it 166 and So if we I'm just gonna draw this on here right now. So I have it So if it closed at 166 Then we would look at about 170 and a half ish So kind of right in here is the expected move and it opened up way up here Now all day it was kind of bouncing high. It's kind of bouncing this level and higher So we never put on a short put vertical, but we will potentially look to do that next week With this huge down move I just didn't want to fight the movement in the market And so and we didn't I had I had an order in but we never got filled because it bounced higher And then I took it off But if we get a little bit of a you know a sell-off in the early next week, we might look to Add a short put vertical here to see if we can get a little bit of a continuation to the upside in John Deere and then we've got our We've got our short Delta position on here Which obviously after earnings busted out of our range so looking for some downside to to get back into range there DIA we've got these two sets of short call verticals This one's hanging out right inside range here. That was in March, and then we've got the one in April Where it's hanging out right here. So again, just holding both of these for some of that short Delta exposure Mentioned Google IWM. Yeah, I mentioned that one QQQ very similar to DIA So we've got one in March see prices just outside the range looking for some more downside to benefit that and then We've got the one in April Right there Mentioned Roku SMH. We've had this short strangle on and price has been hanging out in the upper end of the range Finally got this down movement back into center not enough profit to book yet, but Holding that and if we get some applied volatility contraction next week, we could potentially be able to book that one maybe later in the week SPX I mentioned SPY we've got this A short call vertical from a previous iron condor just holding that for some more downside protection Our bunker trade we've prices hanging out right here. And so obviously we need a big move This is for that tail risk protection in You know if we get a real move to the downside I mean keep in mind when I say real down in my if we look at going back to SPX We look at the chart. I mean We're still near all-time high I mean that that feels like a huge down move that we had on Thursday and Friday But the reality is all-time highs are 33 93. We're only at 33 37. We're you know This is nothing. This is nothing of a down move And so remember these Vicks bunker trades are to protect us against real down moves where we were you know We'd get down into this kind of area here and that Vicks really spikes And so still continuing to hold that bunker trade and remember we'll hold this down all the way down to a point where There's 60 days expiration. So we got a long time left in this one. So nothing to do there Mention XBI and then lastly XLK We've got this long-put vertical on holding for that short Delta exposure so those short Delta positions helped us out this week and Well, and as I mentioned in the community, you know, if we go back to ES I mean, if we get some, you know, continuation to the downside and we get it and we get a little bit of a bounce I would look to add more short Delta, you know Like I said, we're about one to one or about one to one one and a half to one on our ratio And so I wouldn't mind adding some more in I'm just not trying to catch a top, you know Obviously, we wish we would have done it up here and caught those two days I would have been sweet, but that's not how it works You know, if we get this if we get this continuation of a downside and then we get a little bit of a bounce We will enter some more short Delta at that point and see if we can get a continuation to the downside So that is the goal. The other thing I wanted to mention is I know our alerts delivery System had an issue. They had one last week and then they had one this week on Friday And so a We are a new alerts delivery system. We're testing it, but it's it's it's very super super reliable So we can't wait to roll that out. That's that's number one number two the reason that we post the alerts in so many different areas is because you know Technology is great these days, but sometimes technology fails us And so I just want you to understand that, you know, we send text messages We send emails we post in the membership area at navigation trading calm and we post in the community So there's four different spots. So, you know, what I would tell you is if for some reason if if the alerts delivery system Is not working we always post in the community in that VIP pro group. That's what that's designed for So if you are, you know, the markets open at 8 30 central 9 30 Eastern, right? I mean if you don't see any alerts within the first 30 60 minutes of the day you need to be checked in that community because that's where all the updates are posted and we also you know make sure that you have your Notifications set, you know, if you go up to this bell right here This is the best way to track all notifications in the community and if you go down here to the settings wheel And you can click and set your updates so that you receive notifications because when we post in the VIP pro group We also hit notify so but if you don't have your notifications set up so that you receive them either on the mobile app Or by email or however you want to get them make sure you have those Different things checked. Okay, so That's all I got for y'all hope everybody has a great weekend and hopefully we get some continued Volatility next week. Good stuff. This is when training really gets fun. Have a good weekend. Talk to you next week


So we're here at the SID display week here in the iZone and who are you? I'm Alex Hansen. I currently work for South China University and we're developing reflective displays, electronic paper displays to be precise. So what are you showing right here? What we're showing is a prototype of our full-color electronic paper display, which is built up of three layers, cyan, magenta and yellow. And it will be able to show 40% reflectance in a 50% NTSC color gamut. This is the only grail that everybody always wanted for electronic paper. So that means great colors and good visibility? Great colors, good visibility. Lembertion reflectance means that the light goes everywhere, not just in this narrow angle. And it's lightening fast, it switches in three milliseconds from one color to another. What is this? The small one next to it is actually the same display as the large one, but this time it's only an active matrix backplane. It shows the actual resolution that's possible with these types of displays. So even the color display is capable of displaying this resolution. Our limitation here is the fact that we don't have the funds or possibilities to design the transparent TFT display that's necessary for that three-layer system. So that means you can do active matrix, you can do segmented. So these squares are segmented? These squares are segmented. They're actually clusters of 625 small pixels that are linked together by the same electron. Is it battery powered? It's battery powered. Can you take it out? Sure. So is there any chance you can do active matrix like this? Yes, absolutely. That's our next step. As colorful as this? As colorful as this. Right now I'm using my headlight, but if I don't it's still the viewing angles. So how is it different from the other, from e-ink for example? Well from e-ink we're using a totally different system. So our system is based on electro-wetting. That means we're depending on a very thin film of ink that is covering our pixel. But if we switch on the electric power, then that film of ink withdraws into the corner. And if it withdraws into the corner it leaves 90% of the pixel open, which is transparent. So we can do exactly the same as ink on paper. Switch a cyan, magenta, yellow color system. And have the same colorfulness and the same reflectance as a real piece of paper with printed images of it. So is it similar to liquid vista? It is similar to liquid vista, yeah. But we did a different way of mathematics. Liquid vista used RGB color filters to make their color panel. That means that immediately they suffer from a lack of reflectance. Their white state was too dark, so they had to start optimizing the light output again, more or less similar to what a core reflective LCD would do. We didn't cut the corners, we decided to go for the three-layer system immediately and do the maths that is necessary to make it really bright. And once you get the really bright white state, you get the colorfulness for film. So that's what we did. And is this showing what's inside? The three layers here are showing what's inside. These three displays are the three single layers of the display. You can see that by mixing the three separate colors you can actually get all the colors you need. So red, green, blue. How many colors you can get? In principle an infinite number of colors because the system responds in an analog way to a voltage. So we do have a display driver that will display 64 levels of gray for each of the layers. And so in principle we can do a million cores. Millions? Yep. And these are different demos right here? These are different demos. So we've made a few demos in various cores. So a red one, a blue one. There are all single-layer demos to show that each of the cores works perfectly well with an active matrix at high resolution. We've got a few larger size demos in black and white. How's the visibility in black and white compared to like eating? How's the contrast? At least the same I would say. At least the same? At least the same. So these are just prototypes and demos. Our contrast ratio can reach 100 to 1. So that's the best possible? What's 100 to 1? Is it like taper? Well, 100 to 1 is way better than paper. Paper at the maximum is about 20 to 1. And that is high quality glossy paper. A newspaper does 5 to 1. So anything between 5 to 1 and 20 to 1 would be considered good print. And so what's the frame rate? What is this demo right here? This demo is just an example of what you can do by tiling these 8x8 panel displays if some idea of an application. Switching speed is about 3 ms so we can do something like 200 Hz refresh in this style. More than video speed. Oh yeah, well more than video speed. Actually the refresh time of these panels make them ideal for gaming because you can actually display very fast changes. Much faster than, as they say, most LCDs. So how long have you been working on this? The Electro-Wetting principle has been worked on by various people for the last 15 years. We have been developing, it came out of Holland, Phillips originally. I am also from Holland. Also from Phillips. I started in a different area from Phillips so we did electronic paper display, we did a collaboration with E-Ink at some point and over the last 3 years I've been getting more and more involved in the Electro-Wetting system because it promises exactly this which is something that I've devoted the last 15 years to which is creating a real reflective core display. Were you involved with IREX? Absolutely, I was one of the founders of IREX. You were the founders of IREX. It was my dream device, it was amazing. It was just some soft marketing, I guess marketing. Isn't it marketing? It's all about cash and marketing. It's all about cash, marketing and finance. Sell millions, why didn't you sell millions of the IREX? One of the things it was fairly expensive to start with. And the other thing is that when we really needed the money, the economic crisis hit. So that was the end of it. Our bank toppled. So we couldn't simply finance our company anymore. But Holland stood? Holland stood. And just two brushes was left? Yeah, something like that. Two brushes and medical systems I think. But they're great, I love my first toothbrush. Yeah, absolutely. So why is your dream the electoral rating? No, my dream is not specifically the electoral rating. What I want to do is make true core video paper. It wasn't there. That's the ultimate dream of the whole world, of the SID. Of the SID, but also of the rest of the world. We want to have battery powered stuff that lasts for years. And we want to make it sunlight readable. And actually, if you write down the specifications, this color thing is getting very, very close to what it should be. Finally. Is it because you kept improving? Not just like what was the electoral rating of 15 years ago? It's improving? It's improving. We start understanding better how to handle the electoral rating system. We start understanding better why some of the solutions work and why others don't. And we are getting the opportunity to test processing and test various optical solutions. So that's helping us ahead at this moment. But there has to be some issue, right? Is there any issue about the electoral rating? Oh, of course there are issues. There are issues in the sense that it's difficult to maintain the quality. We know how to break these things. It's very easy. So addressing is a very critical item. Addressing? So we need to make sure that the voltage isn't getting too high or that we don't apply too much DC voltage on the panel. Just like any other display technology, we're using a DC drive to energize the pixel. That means that if we apply a voltage on the pixel and we switch off the whole panel, the pixel will stay on. So by stable? Well, it is not in the real sense by stable. It requires so little power that the pixel capacitor of a TFT panel will keep it on for several minutes. And so we can remove the power and the display itself will stay as it is, including all the gray levels. So if the dream device comes out and there's like a device with the active matrix color and everything and the kids are reading something, how long does the battery go to last? Oh, to my expectation, a year. A year? Yeah. If you don't do anything other with it, such as wireless communication, et cetera, the display itself can display more or less still information for several years from a single battery. So the limiting factor is electronics. Whatever you do with it to make it more power hungry is going to drain the battery, but it's not going to be the display. Is this the Guangzhou? Or no, Guangzhou. And is this a real place? This is a real place. In Guangzhou? Yes. So what's going on there? What we have here is a number of images from our 2.5 generation assembly line, where we can, in gloss, print our various structures that we need for the panel. But is for any kind of other project? No, this is dedicated for this. For this project? Yes. Just for electrowetting. But what do you call it? What is the name of your display? Well, we call it an electrowetting display, but we haven't. You call it the great display. Our company is great up to electronics in Hong Kong. We haven't found a name for this, but maybe it's a good idea. Just great. Okay, so what's next? You hear the SID display week, you're looking for partners to make it even bigger? What's the... Our next step is to find a way to productize this. To productize? You've already mentioned that we should go to a higher-resolution full-color display to demonstrate what it can do. Now, for most of the people inside the display community, this will demonstrate what it can do sufficiently. But building a real high-resolution prototype will probably be necessary for the next couple of months. You can just do it in a couple of months, right? You fast? If we have the money, we can do it in a couple of months. Because the development will require making a dedicated TFT matrix panel. And that means that somebody will have to pay for the mask set that will be necessary to do so. How much does it cost? We're looking for that. Well, typically between $300,000 and $500,000. But I would think that 90% of the money for display technology comes from China, right? Yep. And talking about Taiwan and Korea, they need to come with new ideas, but maybe China can come with new ideas. China is coming with new ideas, you can see that. Right here. But it just needs to do the last step. We need to take the last step. Crossing the finish line, right? Interestingly, this prototype is only a month old. So actually this device itself was manufactured last week in our prototype line. So you rushed for the SID? We rushed for the SID. So we would have had the smaller displays look brighter according to the same principle. We didn't manage to get them here in time.  All right. So it's so new at this moment that we haven't had a chance to mobilize China yet. So do you have a children? Yep. Grand? Not yet. Yeah, yeah. Because you need to make the displays ready for when they have to go to school, right? Yeah, well, in principle, yes. So how long do you have to get it working? Well, let's say I spent the last 20 years trying to make it work. I can manage another couple of years.